Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto

Agent Lord and Company

Pub. Number AU-B-2002308295

PCT Number PCT/EP02/01832

PCT Pub. Number WO2002/072598

Priority 60/274,959 12.03.01 US

Filing date 21 February 2002

Wipo publication date 24 September 2002

Acceptance publication date 23 August 2007

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane